Cargando…
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
SARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting strong immunity that is further boosted by previous infection. However, it is unclear whether these immune responses are affected by the interval between infection and vaccination. Over a 2-month period, we evaluated...
Autores principales: | Buckner, Clarisa M., Kardava, Lela, El Merhebi, Omar, Narpala, Sandeep R., Serebryannyy, Leonid, Lin, Bob C., Wang, Wei, Zhang, Xiaozhen, Lopes de Assis, Felipe, Kelly, Sophie E.M., Teng, I-Ting, McCormack, Genevieve E., Praiss, Lauren H., Seamon, Catherine A., Rai, M. Ali, Kalish, Heather, Kwong, Peter D., Proschan, Michael A., McDermott, Adrian B., Fauci, Anthony S., Chun, Tae-Wook, Moir, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513331/ https://www.ncbi.nlm.nih.gov/pubmed/36257313 http://dx.doi.org/10.1016/j.cell.2022.09.032 |
Ejemplares similares
-
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination
por: Buckner, Clarisa M., et al.
Publicado: (2022) -
B-Cell Responses to Sars-Cov-2 mRNA Vaccines
por: Kardava, Lela, et al.
Publicado: (2022) -
Early human B cell signatures of the primary antibody response to mRNA vaccination
por: Kardava, Lela, et al.
Publicado: (2022) -
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine
por: Kardava, Lela, et al.
Publicado: (2021) -
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
por: Lopes de Assis, Felipe, et al.
Publicado: (2023)